Ottilie, Sabine
Luth, Madeline R.
Hellemann, Erich http://orcid.org/0000-0002-5565-8614
Goldgof, Gregory M.
Vigil, Eddy
Kumar, Prianka
Cheung, Andrea L.
Song, Miranda http://orcid.org/0000-0003-4448-277X
Godinez-Macias, Karla P.
Carolino, Krypton
Yang, Jennifer
Lopez, Gisel
Abraham, Matthew
Tarsio, Maureen
LeBlanc, Emmanuelle http://orcid.org/0000-0003-4278-0984
Whitesell, Luke http://orcid.org/0000-0001-6445-5766
Schenken, Jake
Gunawan, Felicia
Patel, Reysha
Smith, Joshua
Love, Melissa S.
Williams, Roy M.
McNamara, Case W.
Gerwick, William H. http://orcid.org/0000-0003-1403-4458
Ideker, Trey
Suzuki, Yo
Wirth, Dyann F.
Lukens, Amanda K.
Kane, Patricia M.
Cowen, Leah E. http://orcid.org/0000-0001-5797-0110
Durrant, Jacob D.
Winzeler, Elizabeth A. http://orcid.org/0000-0002-4049-2113
Funding for this research was provided by:
Bill and Melinda Gates Foundation (OPP1054480, OPP1141300, OPP1171497, OPP1107194)
Bill and Melinda Gates Foundation
Bill and Melinda Gates Foundation
U.S. Department of Health & Human Services | National Institutes of Health (GM085764, R01AI120958-01A1, GM127364)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (GM008666)
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
Bill and Melinda Gates Foundation
Article History
Received: 4 June 2021
Accepted: 21 January 2022
First Online: 11 February 2022
Competing interests
: The authors declare the following competing interests: L.E.C. and L.W. are co-founders and shareholders in Bright Angel Therapeutics, a platform company for development of novel antifungal therapeutics. L.E.C. is a consultant for Boragen, a small-molecule development company focused on leveraging the unique chemical properties of boron chemistry for crop protection and animal health. The remaining authors declare no competing interests.